Cargando…
Hydroxychloroquine versus Azithromycin for Hospitalized Patients with Suspected or Confirmed COVID-19 (HAHPS). Protocol for a Pragmatic, Open-Label, Active Comparator Trial
Coronavirus disease (COVID-19) is a potentially fatal illness with no proven therapy beyond excellent supportive care. Treatments are urgently sought. Adaptations to traditional trial logistics and design to allow rapid implementation, evaluation of trials within a global trials context, flexible in...
Autores principales: | Brown, Samuel M., Peltan, Ithan D., Webb, Brandon, Kumar, Naresh, Starr, Nathan, Grissom, Colin, Buckel, Whitney R., Srivastava, Raj, Harris, Estelle S., Leither, Lindsay M., Johnson, Stacy A., Paine, Robert, Greene, Tom |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Thoracic Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7393787/ https://www.ncbi.nlm.nih.gov/pubmed/32425051 http://dx.doi.org/10.1513/AnnalsATS.202004-309SD |
Ejemplares similares
-
Hydroxychloroquine versus Azithromycin for Hospitalized Patients with COVID-19. Results of a Randomized, Active Comparator Trial
por: Brown, Samuel M., et al.
Publicado: (2021) -
Rationale and Design of ORCHID: A Randomized Placebo-controlled Clinical Trial of Hydroxychloroquine for Adults Hospitalized with COVID-19
por: Casey, Jonathan D., et al.
Publicado: (2020) -
Rationale and design of the pragmatic randomized trial of icosapent ethyl for high cardiovascular risk adults (MITIGATE)
por: Ambrosy, Andrew P., et al.
Publicado: (2021) -
Care of the Seriously Ill Patient with SARS-CoV-2
por: Leither, Lindsay M., et al.
Publicado: (2022) -
Natriuresis‐guided therapy in acute heart failure: rationale and design of the Pragmatic Urinary Sodium‐based treatment algoritHm in Acute Heart Failure (PUSH‐AHF) trial
por: ter Maaten, Jozine M., et al.
Publicado: (2022)